PDCD1 and neoplasm: ONCR-177 also encodes five transgenes intended to boost anti-tumor immunity, including IL-12, Fms-like tyrosine kinase 3 ligand, C-C motif chemokine ligand 4, and antagonists to CTLA-4 and PD-1 (Figure 3E).